Dr Peter Varnai is a Principal Consultant based in the UK office of Technopolis Group and responsible for the Group’s Health Business Unit. Peter has over 15 years of experience in research, education and consulting, including programme evaluations, impact assessments and strategic work for national and international clients. Peter has a broad interest in linking research and innovation programmes to policy and business applications. Peter is expert in designing programme logic frames, developing indicators and implementing those to track programme achievements. Peter applies methods ranging from quantitative modelling to qualitative techniques including interviews and case studies.
Peter is a highly experienced consultant with recent relevant work including the economic impact study of the EU Paediatric Regulation for DG SANTE; healthcare investment trend analysis for EIB, future digital health services in Europe for ESPON; and the evaluation of the Science in Society programme of FP7 for DG RTD. Peter recently completed a study on the value of UK medical research for a consortium of UK medical research funders and charities; a study assessing the research potential of access to clinical trial data for the Wellcome Trust; a review of stakeholder engagement as part of Cochrane’s strategic review, and a review of evidence on health information data for decision-making for EVIPNet, WHO.
Prior to joining Technopolis Group, Peter led a research group in computational drug discovery at the University of Sussex; conducted research as Wellcome Trust International Prize fellow at the University of Cambridge and at the CNRS in France. He is a Fellow of the Royal Society of Chemistry (UK) and has published widely in leading scientific journals. Peter trained originally as a pharmaceutical engineer and obtained MEng degree from Budapest University of Technology and Economics in 1996. Peter also holds a DPhil from the University of Oxford and an MBA from Imperial College Business School. Peter works in English and French.